Greater Cannabis Company (GCAN) EBIT Growth (3y) (2020 - 2026)
Greater Cannabis Company (GCAN) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 4.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 40.17% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 5.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.44% |
| Dec 31, 2025 | -8.38% |
| Sep 30, 2025 | 8.79% |
| Jun 30, 2025 | -3.89% |
| Mar 31, 2025 | -0.86% |
| Dec 31, 2024 | 32.08% |
| Sep 30, 2024 | 18.36% |
| Jun 30, 2024 | 14.35% |
| Mar 31, 2024 | 23.27% |
| Dec 31, 2023 | 6.31% |
| Sep 30, 2023 | 10.72% |
| Jun 30, 2023 | 20.34% |
| Mar 31, 2023 | 23.48% |
| Dec 31, 2022 | 39.90% |
| Sep 30, 2022 | 14.34% |
| Jun 30, 2022 | 35.86% |
| Mar 31, 2022 | 21.90% |
| Dec 31, 2021 | -16.39% |
| Sep 30, 2021 | 28.18% |
| Jun 30, 2021 | -68.68% |